Literature DB >> 19586941

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Sigurdur Y Kristinsson1, Lynn R Goldin, Magnus Björkholm, Jill Koshiol, Ingemar Turesson, Ola Landgren.   

Abstract

There are data to support a role for genetic and immune-related factors in the pathogenesis of lymphomas and plasma cell diseases. In this paper, we review our published large population-based studies and other relevant studies in Hodgkin's and non-Hodgkin's lymphomas, multiple myeloma, and the precursor condition monoclonal gammopathy of undetermined significance. We discuss the overlap in risk factors between related malignancies and explore the underlying mechanisms. Based on these studies, we provide clinical implications and discuss the relevance of these data for patient counseling and clinical follow-up. Finally, we suggest future directions for new studies designed to increase our current knowledge and to define underlying biological mechanisms of our findings.

Entities:  

Mesh:

Year:  2009        PMID: 19586941      PMCID: PMC2770969          DOI: 10.3324/haematol.2009.008979

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  90 in total

Review 1.  Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases.

Authors:  Ola Landgren; Robert A Kyle
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

Review 2.  Susceptibility genes and B-chronic lymphocytic leukaemia.

Authors:  Susan L Slager; Neil E Kay; Zachary S Fredericksen; Alice H Wang; Mark Liebow; Julie M Cunningham; Celine M Vachon; Timothy G Call; James R Cerhan
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

3.  Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.

Authors:  W Zheng; M S Linet; X O Shu; R P Pan; Y T Gao; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

4.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

Review 5.  B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.

Authors:  Arne Hansen; Peter E Lipsky; Thomas Dörner
Journal:  Nat Clin Pract Rheumatol       Date:  2007-10

6.  Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.

Authors:  Lene Mellemkjaer; Ruth M Pfeiffer; Eric A Engels; Gloria Gridley; William Wheeler; Kari Hemminki; Jørgen H Olsen; Lene Dreyer; Martha S Linet; Lynn R Goldin; Ola Landgren
Journal:  Arthritis Rheum       Date:  2008-03

7.  Incidence of cancer among patients with rheumatoid arthritis.

Authors:  G Gridley; J K McLaughlin; A Ekbom; L Klareskog; H O Adami; D G Hacker; R Hoover; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1993-02-17       Impact factor: 13.506

8.  Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Authors:  Karin Ekström Smedby; Claire M Vajdic; Michael Falster; Eric A Engels; Otoniel Martínez-Maza; Jennifer Turner; Henrik Hjalgrim; Paolo Vineis; Adele Seniori Costantini; Paige M Bracci; Elizabeth A Holly; Eleanor Willett; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Nikolaus Becker; Silvia De Sanjosé; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Andrew E Grulich; Wendy Cozen
Journal:  Blood       Date:  2008-02-08       Impact factor: 22.113

9.  Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.

Authors:  Ola Landgren; Jerry A Katzmann; Ann W Hsing; Ruth M Pfeiffer; Robert A Kyle; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew A Adjei; Dirk R Larson; Angela Dispenzieri; L Joseph Melton; Lynn R Goldin; Mary L McMaster; Neil E Caporaso; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2007-12       Impact factor: 7.616

10.  A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.

Authors:  Gabrielle S Sellick; Lynn R Goldin; Ruth W Wild; Susan L Slager; Laura Ressenti; Sara S Strom; Martin J S Dyer; Francesca R Mauro; Gerald E Marti; Stephen Fuller; Matthew Lyttelton; Thomas J Kipps; Michael J Keating; Timothy G Call; Daniel Catovsky; Neil Caporaso; Richard S Houlston
Journal:  Blood       Date:  2007-08-08       Impact factor: 22.113

View more
  20 in total

Review 1.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

Review 2.  Second malignancies after multiple myeloma: from 1960s to 2010s.

Authors:  Anish Thomas; Sham Mailankody; Neha Korde; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2012-02-06       Impact factor: 22.113

3.  Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases.

Authors:  Nada Suvajdzic; Predrag Djurdjevic; Milena Todorovic; Maja Perunicic; Roksanda Stojanović; Aleksandra Novkovic; Biljana Mihaljevic
Journal:  Med Oncol       Date:  2011-07-14       Impact factor: 3.064

Review 4.  Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma.

Authors:  Brendan M Weiss; W Michael Kuehl
Journal:  Expert Rev Hematol       Date:  2010-04       Impact factor: 2.929

5.  Pathophysiology of Waldenström's macroglobulinemia.

Authors:  Marvin J Stone; Virginia Pascual
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 6.  Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.

Authors:  Neha Korde; Sigurdur Y Kristinsson; Ola Landgren
Journal:  Blood       Date:  2011-03-25       Impact factor: 22.113

7.  Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.

Authors:  O Landgren; B I Graubard; J A Katzmann; R A Kyle; I Ahmadizadeh; R Clark; S K Kumar; A Dispenzieri; A J Greenberg; T M Therneau; L J Melton; N Caporaso; N Korde; M Roschewski; R Costello; G M McQuillan; S V Rajkumar
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

8.  Variation in innate immunity genes and risk of multiple myeloma.

Authors:  Mark P Purdue; Qing Lan; Idan Menashe; Tongzhang Zheng; Yawei Zhang; Meredith Yeager; H Dean Hosgood; Shelia H Zahm; Stephen J Chanock; Nathaniel Rothman; Dalsu Baris
Journal:  Hematol Oncol       Date:  2011-03       Impact factor: 5.271

9.  Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population.

Authors:  Dennis E K Tan; Jia Nee Foo; Jin-Xin Bei; Jiang Chang; Roujun Peng; Xiaohui Zheng; Lixuan Wei; Ying Huang; Wei Yen Lim; Juan Li; Qian Cui; Soo Hong Chew; Richard P Ebstein; Ponnudurai Kuperan; Soon Thye Lim; Miriam Tao; Suat Hoon Tan; Alvin Wong; Gee Chuan Wong; Soo Yong Tan; Siok Bian Ng; Yi-Xin Zeng; Chiea Chuen Khor; Dongxin Lin; Adeline L H Seow; Wei-Hua Jia; Jianjun Liu
Journal:  Nat Genet       Date:  2013-06-09       Impact factor: 38.330

10.  Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.

Authors:  Leah H Schinasi; Elizabeth E Brown; Nicola J Camp; Sophia S Wang; Jonathan N Hofmann; Brian C Chiu; Lucia Miligi; Laura E Beane Freeman; Silvia de Sanjose; Leslie Bernstein; Alain Monnereau; Jacqueline Clavel; Guido J Tricot; Djordje Atanackovic; Pierluigi Cocco; Laurent Orsi; James A Dosman; John R McLaughlin; Mark P Purdue; Wendy Cozen; John J Spinelli; Anneclaire J de Roos
Journal:  Br J Haematol       Date:  2016-06-22       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.